In adults with HIV-1 suppressed on dual therapy, taking it 4 days a week failed non-inferiority vs 7 days a week: virological failure at week 48 in 8/219 (4%) vs 0/214 (adjusted difference 3.7%, 95% CI 1.2-6.2).
RCTn = 441
Landman et al. Short-cycle 4-days-per-week maintenance two-drug therapy in people living with HIV (ANRS-177 DUETTO): a randomised, open-label, multicentre, non-inferiority trial